Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14380209Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$2.6M
Full award amounts, FY2025
Award Records
12
Records listing this PI
Award-Linked Rank
#4,355
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2025): $2.6M in linked award amounts across 12 award records · Award-linked rank #4355.
FY2025 award records by amount
NIH award records listing Matthew Hall as a PI. Multi-PI records show the full award amount for context.
- 1ZIATR000435-05ZIANCATS OpenData Portal: an open science resource to share drug discovery and repurposing data in real time$435.5Kaward amount
- 1ZIATR000461-04ZIADevelopment of inhibitors of biliverdin reductase for toxic hyperbilirubinemia$279Kaward amount
- 1ZIATR000537-01ZIADevelopment of affinity selection mass spectrometry methods$279Kaward amount
- 1ZIATR000539-01ZIAIdentification of small molecules capable of lowering prion protein expression$279Kaward amount
- 1ZIATR000577-01ZIADevelopment of N546K and K656E Mutant FGFR Small Molecule Inhibitors$279Kaward amount
- 1ZIATR000536-01ZIAIdentification of small molecules with selective cytotoxicity toward UGT3A2 KO cells$279Kaward amount
- 1ZIATR000542-01ZIAIdentification of small molecules targeting KRAS effectors$209.2Kaward amount
- 1ZIATR000400-06ZIAProfiling of methyltransferases$139.5Kaward amount
- 1ZIATR000418-06ZIAScreening for novel inhibitors of Glutathione Peroxidase 1 and 4$139.5Kaward amount
- 1ZIATR000543-01ZIADevelopment of MENA EVH1 inhibitors to prevent cancer metastasis$139.5Kaward amount
+2 more grants not shown.
Award organization
Organizations that administered FY2025 awards listing Matthew Hall as a PI.
FY2025 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardNational Center for Advancing Translational Sciences
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #4355
- 2025Entered Top 25% NationallyRanked #4355